HI
ACAD icon

Horizon Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Horizon Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534 Sell
24
-55,332
-100% -$1.32M ﹤0.01% 1362
2025
Q4 		$1.48M Sell
55,356
-25,616
-32% -$612K 0.02% 541
2025
Q3 		$1.73M Buy
80,972
+49,819
+160% +$1.18M 0.02% 498
2025
Q2 		$672K Buy
+31,153
New +$579K 0.01% 668
2025
Q1 		– Sell
-824
Closed -$15.1K – 862
2024
Q4 		$15.1K Buy
+824
New +$13.3K ﹤0.01% 668

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Horizon Investments's ACAD Position: Q1 2026 in Review

Horizon Investments reduced its Acadia Pharmaceuticals (ACAD) stake by 100% in Q1 2026, selling an estimated $1.32M and leaving 24 shares worth $534. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

Horizon Investments first reported a position in ACAD in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.73M in Q3 2025. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Horizon Investments held 24 shares of Acadia Pharmaceuticals worth $534 as of Q1 2026.
  • Horizon Investments sold 55,332 Acadia Pharmaceuticals shares in Q1 2026, an estimated $1.32M.
  • Acadia Pharmaceuticals made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #1362 holding.
  • Horizon Investments first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Horizon Investments's Acadia Pharmaceuticals position peaked at $1.73M in Q3 2025.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.